Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Targeted Lipid Control in Very-high-risk Indian Patients: Expert Insights
Author(s): Kausik Ray , Upendra Kaul , Srinivasa Rao , et al Added: 5 months ago

Guidelines & Statements
30th Annual Meeting of the ISCP
Author(s): Jessica Ares-Blanco , Miguel García-Villarino , Carmen Lambert , et al Added: 1 month ago

Prevention & Chronic Conditions

Demographic
AHA 24 Late-Breaking Discussion: The ZODIAC Trial
Author(s): Harriette Van Spall , Kausik Ray Added: 1 year ago
AHA Conference 2024 — Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS patients.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Kausik Ray (Imperial College London, UK) to discuss the findings from the randomized controlled ZODIAC trial assessing decision support systems (DSS) in optimising… View more

Prevention & Chronic Conditions

MI/ACS
30th Annual Meeting of the ISCP
Author(s): Miguel García-Villarino , Elias Delgado , Carmen Lambert , et al Added: 1 month ago

Prevention & Chronic Conditions

Demographic
Lipid-lowering Therapies and Lp(a)
Author(s): Stephen Nicholls , Adam J Nelson Added: 1 month ago

Prevention & Chronic Conditions
New Horizons in Dyslipidaemia
Author(s): Peter Libby, Kausik Ray, Erik Stroes Start date: Feb 12, 2026
Join us forNew Horizons in Dyslipidaemia, a new one-day virtual educational event, taking place on 12 February 2026, designed for healthcare professionals involved in the management of cardiovascular risk and other lipid-related health conditions.This event will explore the rapidly evolving landscape of lipid management, addressing persistent gaps between perceived and actual cardiovascular risk… View more

Prevention & Chronic Conditions
New Horizons in Dyslipidaemia 2026
NHD 2026

Video Series

Author(s): Kausik Ray , Erik Stroes , Nicholas Marston , et al Added: 3 months ago
Watch the on-demand version of New Horizons in Dyslipidaemia (NHD) 2026, a virtual educational event designed for healthcare professionals involved in the management of cardiovascular risk and other lipid-related conditions.The programme is led by course directors Dr Peter Libby (Brigham and Women’s Hospital, Boston, US), Prof Kausik Ray (Imperial College London, London, UK) and Prof Erik Stroes … View more

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions
ANGPTL3 Gene Editing: Promise and Prudence
Author(s): Alberto Lorenzatti Added: 2 months ago

Prevention & Chronic Conditions
New Horizons in Dyslipidaemia 2026
Start date: Feb 12, 2026 End date: Feb 12, 2026
New Horizons in Dyslipidaemia is a free-to-access, one-day virtual educational event on 12 February 2026, developed for healthcare professionals involved in cardiovascular risk assessment and lipid management.The programme will explore the rapidly evolving landscape of lipid management, addressing gaps between perceived and actual cardiovascular risk and the underutilisation of effective… View more

Prevention & Chronic Conditions
New Horizons in Dyslipidaemia 2026
Added: 4 months ago Source:  Radcliffe CVRM
Radcliffe Cardiology has announced New Horizons in Dyslipidaemia 2026, a live virtual event on 12 February 2026 (14:00–17:55 GMT) that will convene twelve international leaders to examine how lipid management is evolving, and where current practice continues to fall short.Despite the availability of highly effective lipid-lowering therapies, residual cardiovascular risk remains common. At the… View more

Guidelines & Statements

Prevention & Chronic Conditions